Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
CASE REPORT  

 Article Access Statistics
    Viewed1851    
    Printed111    
    Emailed0    
    PDF Downloaded128    
    Comments [Add]    

Recommend this journal


Click on image for details.

 Closure of insufficient, native right ventricular outflow tract with AMPLATZER™ muscular ventricular septal defect occluder in a patient with tetralogy of Fallot post-Melody® valve

Neha Bansal, Sanjeev Aggarwal, Daniel R Turner
The Carmen and Ann Adams Department of Pediatrics, Division of Cardiology, The Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA

Correspondence Address:
Dr. Neha Bansal
The Carmen and Ann Adams Department of Pediatrics, Division of Cardiology, The Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/apc.APC_76_18

Rights and Permissions

Year : 2019  |  Volume : 12  |  Issue : 2  |  Page : 159-162

 
SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (1,055 KB)
Email article
Print Article
Add to My List
AMPLATZER™ muscular ventricular septal defect occluder is used commonly for off-label purposes. We describe an unusual case of a patient with tetralogy of Fallot who underwent repair with a right ventricle to pulmonary artery homograft due to abnormal coronary artery pattern. During the initial surgery, the native right ventricular outflow tract was left open. At 30 years of age, he was symptomatic due to severe native right ventricular outflow tract insufficiency. Cardiac MRI confirmed a dilated right ventricle and pulmonary insufficiency through the native right ventricular outflow tract, despite no significant homograft insufficiency due to previous Melody® valve placement. The right ventricular outflow tract was closed successfully using an 18 mm AMPLATZER™ muscular ventricular septal defect occluder. At 5-year follow-up, there is no native right ventricular outflow tract insufficiency and no additional arrhythmia. We suggest that percutaneous closure of the insufficient; native right ventricular outflow tract using a septal occluder is an alternative to surgical management.






[FULL TEXT] [PDF]*
 

 

 Whats new | Sitemap | Feedback | Copyright and Disclaimer | Privacy Notice

 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 CASE REPORT
 



Neha Bansal, Sanjeev Aggarwal, Daniel R Turner
The Carmen and Ann Adams Department of Pediatrics, Division of Cardiology, The Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA

Correspondence Address:
Dr. Neha Bansal
The Carmen and Ann Adams Department of Pediatrics, Division of Cardiology, The Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/apc.APC_76_18

Rights and Permissions

AMPLATZER™ muscular ventricular septal defect occluder is used commonly for off-label purposes. We describe an unusual case of a patient with tetralogy of Fallot who underwent repair with a right ventricle to pulmonary artery homograft due to abnormal coronary artery pattern. During the initial surgery, the native right ventricular outflow tract was left open. At 30 years of age, he was symptomatic due to severe native right ventricular outflow tract insufficiency. Cardiac MRI confirmed a dilated right ventricle and pulmonary insufficiency through the native right ventricular outflow tract, despite no significant homograft insufficiency due to previous Melody® valve placement. The right ventricular outflow tract was closed successfully using an 18 mm AMPLATZER™ muscular ventricular septal defect occluder. At 5-year follow-up, there is no native right ventricular outflow tract insufficiency and no additional arrhythmia. We suggest that percutaneous closure of the insufficient; native right ventricular outflow tract using a septal occluder is an alternative to surgical management.






[FULL TEXT] [PDF]*


        
Print this article     Email this article  

 Whats new | Sitemap | Feedback | Copyright and Disclaimer | Privacy Notice

 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008